Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)

v3.19.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2017 $ 1,046,329 $ 57,744 $ 610,001 $ 379,468 $ (884)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 16,639 [1]     16,639  
Other comprehensive income, (net of taxes) (11,426)       (11,426)
Issuance of common stock in regard to acquisition [2] 794,809 29,156 765,653    
Dividends on common stock (13,808)     (13,808)  
Issuance of common stock under Equity Compensation Plans 927 91 836    
Issuance of common stock for services rendered 184 7 177    
Vesting of restricted stock, net of shares held for taxes, under Equity Compensation Plans (2,270) 93 (2,363)    
Cancellation of warrants (1,530)   (1,530)    
Stock-based compensation expense 1,223   1,223    
Ending balance at Mar. 31, 2018 1,831,077 87,091 1,373,997 382,299 (12,310)
Beginning balance at Dec. 31, 2018 1,924,581 87,250 1,380,259 467,345 (10,273)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 35,631 [1]     35,631  
Other comprehensive income, (net of taxes) 18,670       18,670
Issuance of common stock in regard to acquisition 499,974 21,070 478,904    
Dividends on common stock (18,838)     (18,838)  
Issuance of common stock under Equity Compensation Plans 138 8 130    
Issuance of common stock for services rendered 219 8 211    
Vesting of restricted stock, net of shares held for taxes, under Equity Compensation Plans (1,647) 139 (1,786)    
Cancellation of warrants 0        
Impact of adoption of new guidance [3] 1,133     1,133  
Stock-based compensation expense 1,870   1,870    
Ending balance at Mar. 31, 2019 $ 2,459,465 $ 108,475 $ 1,859,588 $ 483,005 $ 8,397
[1] Discontinued operations have an immaterial impact to the Company's Consolidated Statement of Cash Flows. The change in loans held for sale included in the Operating Activities section for the three months ended March 31, 2018 are fully attributable to discontinued operations
[2] Includes conversion of Xenith warrants to the Company's warrants.
[3] Adoption of ASU No. 2016-02, "Leases (Topic 842)." in the first quarter of 2019.